Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia

Background: Hepatocellular carcinoma (HCC) rarely develops in patients with chronic hepatitis C (CHC) who achieve sustained virological response (SVR). We assessed the incidence of HCC in CHC patients with hemophilia after treatment with pegylated interferon plus ribavirin (PegIFN/RBV) and direct-ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In Jung, Yoo, Sung Hwan, Kim, Sora, Cho, Young Youn, Yoo, Ki Young, Kim, Hyung Joon, Lee, Hyun Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911386/
https://www.ncbi.nlm.nih.gov/pubmed/35268541
http://dx.doi.org/10.3390/jcm11051451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911386/
https://www.ncbi.nlm.nih.gov/pubmed/35268541
http://dx.doi.org/10.3390/jcm11051451

Ejemplares similares